Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10708644.9Aexternal-prioritypatent/EP2406253B1/en
Application filed by Pfizer Inc.filedCriticalPfizer Inc.
Publication of CY1114207T1publicationCriticalpatent/CY1114207T1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Η παρούσα εφεύρεση παρέχει ενώσεις του Τύπου (Ι) που λειτουργούν ως ενεργοποιητές γλυκοκινάσης φαρμακευτικές συνθέσεις αυτών και μεθόδους θεραπευτικής αγωγής ασθενειών, διαταραχών, ή παθήσεων που διαμεσολαβούνται από γλυκοκινάση.The present invention provides compounds of Formula (I) which function as glucokinase activators pharmaceutical compositions thereof and methods of treating glucokinase-mediated diseases, disorders, or diseases.
CY20131100684T2009-03-112013-08-09
Benzofuranyl derivatives for use as glucokinase inhibitors
CY1114207T1
(en)